rs1447458978
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM2PM5PP3_ModeratePP5_Very_Strong
The NM_003361.4(UMOD):c.707C>T(p.Pro236Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000695 in 1,439,028 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P236Q) has been classified as Likely pathogenic.
Frequency
Consequence
NM_003361.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
UMOD | ENST00000396138.9 | c.707C>T | p.Pro236Leu | missense_variant | Exon 3 of 11 | 5 | NM_003361.4 | ENSP00000379442.5 | ||
UMOD | ENST00000396134.6 | c.806C>T | p.Pro269Leu | missense_variant | Exon 4 of 12 | 2 | ENSP00000379438.2 | |||
UMOD | ENST00000570689.5 | c.707C>T | p.Pro236Leu | missense_variant | Exon 3 of 11 | 5 | ENSP00000460548.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000481 AC: 1AN: 207972Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 114752
GnomAD4 exome AF: 6.95e-7 AC: 1AN: 1439028Hom.: 0 Cov.: 35 AF XY: 0.00 AC XY: 0AN XY: 715052
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Pathogenic:2
This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 236 of the UMOD protein (p.Pro236Leu). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This missense change has been observed in individual(s) with juvenile hyperuricemic nephropathy (PMID: 15086896). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 521547). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt UMOD protein function with a positive predictive value of 80%. This variant disrupts the p.Pro236 amino acid residue in UMOD. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 15086896). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
- -
Inborn genetic diseases Pathogenic:1
- -
Familial juvenile hyperuricemic nephropathy type 1 Pathogenic:1
- -
UMOD-related disorder Pathogenic:1
The UMOD c.707C>T variant is predicted to result in the amino acid substitution p.Pro236Leu. This variant was reported in multiple unrelated individuals with juvenile hyperuricemic nephropathy, (Kudo et al. 2004. PubMed ID: 15086896; Bollée et al. 2011. PubMed ID: 21868615; Hureaux et al. 2019. PubMed ID: 31672324; Olinger et al. 2020. PubMed ID: 32450155). This variant is reported in 0.0011% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/16-20359916-G-A). This variant is interpreted as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at